Assessing the treatment of pancreatic ductal adenocarcinoma by deuterium metabolic imaging: a preclinical study

Key Points

• The main aim is to evaluate how treatment affects glucose metabolism in pancreatic ductal adenocarcinoma tumors.
• Conducted preclinical trials using deuterium metabolic imaging to assess tumor metabolism.
• Analyzed metabolic kinetics of glucose in pancreatic ductal adenocarcinoma tumors before and after treatment.
• Treatment significantly alters glucose metabolism in tumors.
• Disruptions in metabolic correlations may indicate whether treatment is successful or not.